Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02188108 · ClinicalTrials.gov registry record · NA

Validation of the Wisconsin Stone-QOL

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
3,299
Enrollment target

NCT02188108: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT02188108 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 3,299 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (135% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02188108, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
3,299 participants
Enrollment target

Study Summary

The overall purpose of this study is to evaluate criterion-related validity of a newly-developed disease-specific instrument to assess the health-related quality of life (HRQOL) of patients who have had kidney stones. Specific aims of this study are: 1. Aim 1. Evaluate the population/external validity (generalizability) of the Wisconsin Stone-QOL by answering the question, "Is the Wisconsin Stone-QOL useful for assessing the HRQOL of patients who form kidney stones from a broad region of North America?" 2. Aim 2. Assess the ability of the Wisconsin Stone-QOL to detect changes within patients related to stone interventions and other disease-specific outcomes by answering the question, "Is the Wisconsin Stone-QOL sensitive to changes in stone-related outcomes within individuals?"

Primary Outcome

Change in HRQOL from baseline to follow-up time points will be assessed

Interventions

  • OTHER Wisconsin Stone-QOL survey

Trial Details

FieldValue
Enrollment Target 3,299 participants
Start Date 2014-07
Est. Completion 2023-06-30
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT02188108 record still lists

NCT02188108 is an interventional study that assigns participants to a tested intervention. Its 3,299 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (135% higher).

The record links to 0 conditions, and to 1 intervention - of which Wisconsin Stone-QOL survey is the first listed.

NCT02188108 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02188108 about?

NCT02188108 is a clinical study titled "Validation of the Wisconsin Stone-QOL". The overall purpose of this study is to evaluate criterion-related validity of a newly-developed disease-specific instrument to assess the health-related quality of life (HRQOL) of patients who have had kidney stones. Specific aims of this study are: 1. Aim 1. Evaluate the population/external valid...

What is the current status of trial NCT02188108?

This trial is currently completed. It is a NA study. The enrollment target is 3,299 participants. The study started on 2014-07. Estimated completion is 2023-06-30.

What interventions are being tested in trial NCT02188108?

The interventions under investigation include: Wisconsin Stone-QOL survey (OTHER).

Who is sponsoring clinical trial NCT02188108?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02188108's enrollment target sits among peer trials

3,299 37th of 2000 higher than 1,964 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07214610 · 3,300 participants · NA

    Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study

  • NCT03674307 · 3,306 participants · NA

    Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates

  • NCT06815536 · 3,291 participants

    Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae

  • NCT06543446 · 3,290 participants · NA

    Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02188108, the US trial registry maintained by the National Library of Medicine. NCT02188108 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.